Fumaric acid

Presentations on Ropeginterferon Alfa-2b During ASH Annual Meeting Highlight Momentum in the Care of Polycythemia Vera

Retrieved on: 
Thursday, November 3, 2022

Follow PharmaEssentia USA on Twitter and LinkedIn to get news and updates on our activity at the ASH Annual Meeting.

Key Points: 
  • Follow PharmaEssentia USA on Twitter and LinkedIn to get news and updates on our activity at the ASH Annual Meeting.
  • PV may result in cardiovascular complications such as thrombosis and embolism, and often transforms to secondary myelofibrosis or leukemia.
  • BESREMi has orphan drug designation for treatment of polycythemia vera (PV) in adults in the United States.
  • Blast Transformation and Fibrotic Progression in Polycythemia Vera and Essential Thrombocythemia: A Literature Review of Incidence and Risk Factors.

Sandoz Canada continues to expand its portfolio of generic products

Retrieved on: 
Wednesday, September 21, 2022

PrSandoz Apixaban SDZ is an important generic equivalent; the market for this product has been growing for the past five years in Canada.

Key Points: 
  • PrSandoz Apixaban SDZ is an important generic equivalent; the market for this product has been growing for the past five years in Canada.
  • BOUCHERVILLE, Quebec, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Sandoz Canada Inc. is proud to announce the launch of several products that will expand its portfolio of high-quality generics.
  • Sandoz Canada is committed to its role in the healthcare sector and our teams are constantly working to expand our product portfolio to improve patient access to affordable, high-quality medicines.
  • Our products will generate substantial savings that can be reinvested for the benefit of Canadians, says Michel Robidoux, President and General Manager of Sandoz Canada.

New Data on Ropeginterferon Alfa-2b to Be Featured at EHA2022

Retrieved on: 
Wednesday, June 8, 2022

PharmaEssentia has licensed ropeginterferon alfa-2b in Europe to AOP.

Key Points: 
  • PharmaEssentia has licensed ropeginterferon alfa-2b in Europe to AOP.
  • PV may result in cardiovascular complications such as thrombosis and embolism, and often transforms to secondary myelofibrosis or leukemia.
  • BESREMi has orphan drug designation for treatment of polycythemia vera (PV) in adults in the United States.
  • BESREMi was approved with a boxed warning for risk of serious disorders including aggravation of neuropsychiatric, autoimmune, ischemic and infectious disorders.

Sandoz Canada launches PrSandoz® Dimethyl Fumarate Delayed-Release Capsules, a generic equivalent to PrTecfidera*

Retrieved on: 
Monday, October 4, 2021

PrSandoz Dimethyl Fumarate Delayed-Release Capsules is an important generic product that will enable major cost savings for the healthcare system in addition to improving access for patients.

Key Points: 
  • PrSandoz Dimethyl Fumarate Delayed-Release Capsules is an important generic product that will enable major cost savings for the healthcare system in addition to improving access for patients.
  • BOUCHERVILLE, Quebec, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of PrSandoz Dimethyl Fumarate Delayed-Release Capsules, a generic equivalent to Biogen Canadas PrTecfidera*.
  • PrSandoz Dimethyl Fumarate Delayed-Release Capsules is available in a blister pack of 56 capsules in two strengths (120 mg and 240 mg).
  • This press release contains forward-looking statements, including, but not limited to, potential future revenues from the sale of PrSandoz Dimethyl Fumarate Delayed-Release Capsules.

Global Fumaric Acid Market Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, April 26, 2021

b'The "Fumaric Acid Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global fumaric acid market reached a value of US$ 660.9 Million in 2020.

Key Points: 
  • b'The "Fumaric Acid Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com\'s offering.\nThe global fumaric acid market reached a value of US$ 660.9 Million in 2020.
  • Looking forward, the global fumaric acid market to exhibit moderate growth during the next five years.\nFumaric acid is a white or colorless crystalline chemical compound with a fruit-like taste.
  • Similar to malic acid, fumaric acid helps in the production of energy from food in the form of ATP.
  • Commercially available in the form of dry powder, liquid or large pellet crystals, fumaric acid is also used in the manufacturing of medicines, animal feed, unsaturated polyester, cleaning agents and printing inks.\nGlobal Fumaric Acid Market Drivers:\nFumaric acid is used as an acidulant, pH controller and flavor enhancer in the food and beverage industry.

Vitalis to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

Retrieved on: 
Tuesday, September 1, 2020

A live audio webcast of the presentation can be accessed through the Media section of the Company's website at www.vitalispharma.com .

Key Points: 
  • A live audio webcast of the presentation can be accessed through the Media section of the Company's website at www.vitalispharma.com .
  • A replay of the webcast will be available on the Company's website following the live presentation.
  • Vitalis is a privately-held specialty pharmaceutical company focused on overcoming the limitations of existing drugs using its proprietary VTS-Aspirin platform.
  • Its most advanced product, VTS-72, uniquely combines aspirin with fumaric acid, the leading multiple sclerosis medication, to reduce its most common side effect while improving pharmacokinetics.

Global Fumaric Acid Market (2019 to 2026) - Size, Share, Outlook and COVID-19 Strategies - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 22, 2020

3.4 Impact of New Entrants, Competitive Landscape, Substitutes, Buyer and Supplier Powers

Key Points: 
  • 3.4 Impact of New Entrants, Competitive Landscape, Substitutes, Buyer and Supplier Powers
    4.1 Asia Pacific Fumaric Acid Market Outlook across Types, 2019 - 2026
    4.2 Europe Fumaric Acid Market Outlook across Types, 2019 - 2026
    4.3 North America Fumaric Acid Market Outlook across Types, 2019 - 2026
    4.4 South and Central America Fumaric Acid Market Outlook across Types, 2019 - 2026
    4.5 Middle East Africa Fumaric Acid Market Outlook across Types, 2019 - 2026
    5.1 Asia Pacific Fumaric Acid Market Outlook across Applications, 2019 - 2026
    5.2 Europe Fumaric Acid Market Outlook across Applications, 2019 - 2026
    5.3 North America Fumaric Acid Market Outlook across Applications, 2019 - 2026
    5.4 South and Central America Fumaric Acid Market Outlook across Applications, 2019 - 2026
    5.5 Middle East Africa Fumaric Acid Market Outlook across Applications, 2019 - 2026
    6.1 The United States Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.2 Canada Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.3 Mexico Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.4 China Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.5 India Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.6 Japan Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.7 South Korea Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.8 Rest of Asia Pacific Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.9 Germany Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.10 United Kingdom Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.11 France Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.12 Spain Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.13 Italy Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.14 Rest of Europe Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.15 Middle East Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.16 Africa Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.17 Brazil Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.18 Argentina Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    6.19 Rest of South and Central America Fumaric Acid Market Analysis and Outlook, $ million, 2019 - 2026
    View source version on businesswire.com: https://www.businesswire.com/news/home/20200722005456/en/

Amid the COVID-19 crisis and the looming economic recession, the Fumaric Acid market worldwide will grow by a projected US$167.2 Million, during the analysis period

Retrieved on: 
Wednesday, May 27, 2020

NEW YORK, May 27, 2020 /PRNewswire/ --Amid the COVID-19 crisis and the looming economic recession, the Fumaric Acid market worldwide will grow by a projected US$167.2 Million, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 3.5%.

Key Points: 
  • NEW YORK, May 27, 2020 /PRNewswire/ --Amid the COVID-19 crisis and the looming economic recession, the Fumaric Acid market worldwide will grow by a projected US$167.2 Million, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 3.5%.
  • An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry.
  • In Japan, the Food Additives segment will reach a market size of US$16.1 Million by the close of the analysis period.
  • Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Fumaric Acid market.

Bartek Ingredients Announces 10,000 MT Malic Acid Capacity Expansion

Retrieved on: 
Tuesday, March 10, 2020

In support of Barteks goal of continuing to invest ahead of growth in the malic and fumaric acid food-grade markets, Bartek is announcing a 10,000 MT malic acid capacity expansion, to be completed in Q1 2021.

Key Points: 
  • In support of Barteks goal of continuing to invest ahead of growth in the malic and fumaric acid food-grade markets, Bartek is announcing a 10,000 MT malic acid capacity expansion, to be completed in Q1 2021.
  • This expansion closely follows the previously announced 4,000 MT malic acid expansion completed in 2019, as well as the installation of a new 22,500 MT maleic anhydride reactor, which will also be operational by Q1 2021.
  • With these expansions, Bartek will have in excess of 30,000 MT of malic acid capacity, sufficient to supply the North American market and meet anticipated global growth.
  • Established in 1969, Bartek Ingredients Inc. is a leading producer of malic acid, fumaric acid, and maleic anhydride.

Global Fumaric Acid Market to 2025: Market is Projected to Grow by $229 Million

Retrieved on: 
Wednesday, November 6, 2019

DUBLIN, Nov. 6, 2019 /PRNewswire/ -- The "Fumaric Acid - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 6, 2019 /PRNewswire/ -- The "Fumaric Acid - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.
  • The Fumaric Acid market worldwide is projected to grow by US$229.2 Million, driven by a compounded growth of 4.8%
    Food Additives, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.4%.
  • The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market.
  • Poised to reach over US$339.4 Million by the year 2025, Food Additives will bring in healthy gains adding significant momentum to global growth.